{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:09:39Z","timestamp":1781824179429,"version":"3.54.5"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009691","name":"Fondation pour la Recherche Nuovo-Soldati","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Edmond de Rothschild Foundations"},{"name":"RadioTransNet-SFRO"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"DOI":"10.1007\/s11912-025-01708-9","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T02:57:39Z","timestamp":1755658659000},"page":"1155-1169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multimodal Imaging to Improve Patient Selection and Optimize Treatment Planning and Delivery for Patients Undergoing Reirradiation: A Scoping Review"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5512-4161","authenticated-orcid":false,"given":"Arnaud","family":"Beddok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rozenblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Calugaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Feuvret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Champion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine Ala","family":"Eddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Crehange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"El Fakhri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ir\u00e8ne","family":"Buvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"1708_CR1","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","volume":"23","author":"N Andratschke","year":"2022","unstructured":"Andratschke N, Willmann J, Appelt AL, Alyamani N, Balermpas P, Baumert BG, et al. European society for radiotherapy and oncology and European organisation for research and treatment of cancer consensus on re-irradiation: definition, reporting, and clinical decision making. Lancet Oncol. 2022;23:e469\u201378.","journal-title":"Lancet Oncol"},{"key":"1708_CR2","doi-asserted-by":"publisher","unstructured":"Beddok A, Willmann J, Embring A, Appelt AL, Balermpas P, Chua K, et al. Reirradiation: standards, challenges, and patient-focused strategies across tumor types. CA Cancer J Clin. 2025. https:\/\/doi.org\/10.3322\/caac.70016","DOI":"10.3322\/caac.70016"},{"key":"1708_CR3","doi-asserted-by":"publisher","first-page":"109947","DOI":"10.1016\/j.radonc.2023.109947","volume":"189","author":"J Willmann","year":"2023","unstructured":"Willmann J, Appelt AL, Balermpas P, Baumert BG, de Ruysscher D, Hoyer M, et al. Re-irradiation in clinical practice: results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platform. Radiother Oncol. 2023;189:109947.","journal-title":"Radiother Oncol"},{"key":"1708_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1470-2045(20)30673-2","volume":"22","author":"Y-P Liu","year":"2021","unstructured":"Liu Y-P, Wen Y-H, Tang J, Wei Y, You R, Zhu X-L, et al. Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet Oncol. 2021;22:381\u201390.","journal-title":"Lancet Oncol"},{"key":"1708_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1208\/s12248-021-00574-0","volume":"23","author":"JD Twomey","year":"2021","unstructured":"Twomey JD, Zhang B. Cancer immunotherapy update: FDA-Approved checkpoint inhibitors and companion diagnostics. AAPS J. 2021;23:39.","journal-title":"AAPS J"},{"key":"1708_CR6","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.3390\/cancers15112917","volume":"15","author":"X Le","year":"2023","unstructured":"Le X, Elamin YY, Zhang J. New actions on actionable mutations in lung cancers. Cancers (Basel). 2023;15:2917.","journal-title":"Cancers (Basel)"},{"key":"1708_CR7","doi-asserted-by":"publisher","first-page":"901390","DOI":"10.3389\/fonc.2022.901390","volume":"12","author":"M Waltenberger","year":"2022","unstructured":"Waltenberger M, Furkel J, R\u00f6hrich M, Salome P, Debus C, Tawk B, et al. The impact of tumor metabolic activity assessed by 18F-FET amino acid PET imaging in particle radiotherapy of high-grade glioma patients. Front Oncol. 2022;12:901390.","journal-title":"Front Oncol"},{"key":"1708_CR8","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.21037\/atm-20-5214","volume":"10","author":"J Hu","year":"2022","unstructured":"Hu J, Yang Z, Gao J, Hu W, Yang J, Qiu X, et al. Pre-treatment FLT-PET parameters as a prognostic tool for patients with locally advanced recurrent nasopharyngeal carcinoma salvaged by carbon-ion radiotherapy: a pilot study. Ann Transl Med. 2022;10:1196.","journal-title":"Ann Transl Med"},{"key":"1708_CR9","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1002\/lary.27173","volume":"128","author":"MA Velez","year":"2018","unstructured":"Velez MA, Veruttipong D, Wang P-C, Abemayor E, St John M, TenNapel M, et al. FDG-PET metabolic tumor parameters for the reirradiation of recurrent head and neck cancer. Laryngoscope. 2018;128:2345\u201350.","journal-title":"Laryngoscope"},{"key":"1708_CR10","doi-asserted-by":"publisher","first-page":"104757","DOI":"10.1016\/j.oraloncology.2020.104757","volume":"107","author":"J Lee","year":"2020","unstructured":"Lee J, Kim WC, Yoon WS, Koom WS, Rim CH. Reirradiation using stereotactic body radiotherapy in the management of recurrent or second primary head and neck cancer: A meta-analysis and systematic review. Oral Oncol. 2020;107:104757.","journal-title":"Oral Oncol"},{"key":"1708_CR11","doi-asserted-by":"publisher","first-page":"e2250607","DOI":"10.1001\/jamanetworkopen.2022.50607","volume":"6","author":"A Lee","year":"2023","unstructured":"Lee A, Woods R, Mahfouz A, Kitpanit S, Cartano O, Mohamed N, et al. Evaluation of proton therapy reirradiation for patients with recurrent head and neck squamous cell carcinoma. JAMA Netw Open. 2023;6:e2250607.","journal-title":"JAMA Netw Open"},{"key":"1708_CR12","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.1200\/JCO.2006.07.9194","volume":"25","author":"CJ Langer","year":"2007","unstructured":"Langer CJ, Harris J, Horwitz EM, Nicolaou N, Kies M, Curran W, et al. Phase II study of Low-Dose Paclitaxel and cisplatin in combination with Split-Course concomitant Twice-Daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of radiation therapy oncology group protocol 9911. JCO. 2007;25:4800\u20135.","journal-title":"JCO"},{"key":"1708_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.oraloncology.2019.08.017","volume":"98","author":"F Dionisi","year":"2019","unstructured":"Dionisi F, Fiorica F, D\u2019Angelo E, Maddalo M, Giacomelli I, Tornari E, et al. Organs at risk\u2019s tolerance and dose limits for head and neck cancer re-irradiation: A literature review. Oral Oncol. 2019;98:35\u201347.","journal-title":"Oral Oncol"},{"key":"1708_CR14","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1007\/s00259-022-05793-x","volume":"49","author":"X Zhao","year":"2022","unstructured":"Zhao X, Liang Y-J, Zhang X, Wen D-X, Fan W, Tang L-Q, et al. Deep learning signatures reveal multiscale intratumor heterogeneity associated with biological functions and survival in recurrent nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2022;49:2972\u201382.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1708_CR15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00259-022-06000-7","volume":"50","author":"A Beddok","year":"2023","unstructured":"Beddok A, Orlhac F, Calugaru V, Champion L, Ala Eddine C, Nioche C, et al. [18F]-FDG PET and MRI radiomic signatures to predict the risk and the location of tumor recurrence after re-irradiation in head and neck cancer. Eur J Nucl Med Mol Imaging. 2023;50:559\u201371.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1708_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13244-021-01017-2","volume":"12","author":"D Albano","year":"2021","unstructured":"Albano D, Benenati M, Bruno A, Bruno F, Calandri M, Caruso D, et al. Imaging side effects and complications of chemotherapy and radiation therapy: a pictorial review from head to toe. Insights Imaging. 2021;12:76.","journal-title":"Insights Imaging"},{"key":"1708_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467\u201373.","journal-title":"Ann Intern Med"},{"key":"1708_CR18","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions [Internet]. [cited 2022 Aug 11]. Available from: https:\/\/training.cochrane.org\/handbook"},{"key":"1708_CR19","unstructured":"Wells GA, Wells G, Shea B, Shea B, O\u2019Connell D, Peterson J et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. 2014."},{"key":"1708_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13244-023-01572-w","volume":"15","author":"B Kocak","year":"2024","unstructured":"Kocak B, Akinci D\u2019Antonoli T, Mercaldo N, Alberich-Bayarri A, Baessler B, Ambrosini I, et al. METhodological radiomics score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII. Insights Imaging. 2024;15:8.","journal-title":"Insights Imaging"},{"key":"1708_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11060-012-0980-7","volume":"110","author":"M Niyazi","year":"2012","unstructured":"Niyazi M, Jansen N, Ganswindt U, Schwarz SB, Geisler J, Schnell O, et al. Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET. J Neurooncol. 2012;110:389\u201395.","journal-title":"J Neurooncol"},{"key":"1708_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1748-717X-9-181","volume":"9","author":"K Miwa","year":"2014","unstructured":"Miwa K, Matsuo M, Ogawa S, Shinoda J, Yokoyama K, Yamada J, et al. Re-irradiation of recurrent glioblastoma multiforme using 11\u00a0C-methionine PET\/CT\/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy. Radiat Oncol. 2014;9:181.","journal-title":"Radiat Oncol"},{"key":"1708_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.radonc.2016.08.014","volume":"121","author":"S Moller","year":"2016","unstructured":"Moller S, Law I, Munck Af Rosenschold P, Costa J, Poulsen HS, Engelholm SA, et al. Prognostic value of 18F-FET PET imaging in re-irradiation of high-grade glioma: results of a phase I clinical trial. Radiother Oncol. 2016;121:132\u20137.","journal-title":"Radiother Oncol"},{"key":"1708_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11060-016-2366-8","volume":"132","author":"DF Fleischmann","year":"2017","unstructured":"Fleischmann DF, Unterrainer M, Bartenstein P, Belka C, Albert NL, Niyazi M. 18F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images? J Neurooncol. 2017;132:277\u201386.","journal-title":"J Neurooncol"},{"key":"1708_CR25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11060-018-2750-7","volume":"137","author":"RS Youland","year":"2018","unstructured":"Youland RS, Pafundi DH, Brinkmann DH, Lowe VJ, Morris JM, Kemp BJ, et al. Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas. J Neurooncol. 2018;137:583\u201391.","journal-title":"J Neurooncol"},{"key":"1708_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11060-018-2859-8","volume":"139","author":"B Wang","year":"2018","unstructured":"Wang B, Zhao P, Zhang Y, Ge M, Lan C, Li C, et al. Quantitative dynamic susceptibility contrast perfusion-weighted imaging-guided customized gamma knife re-irradiation of recurrent high-grade gliomas. J Neurooncol. 2018;139:185\u201393.","journal-title":"J Neurooncol"},{"key":"1708_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.rpor.2018.04.003","volume":"23","author":"H Tanaka","year":"2018","unstructured":"Tanaka H, Yamaguchi T, Hachiya K, Miwa K, Shinoda J, Hayashi M, et al. 11\u00a0C-methionine positron emission tomography for target delineation of recurrent glioblastoma in re-irradiation planning. Rep Pract Oncol Radiother. 2018;23:215\u20139.","journal-title":"Rep Pract Oncol Radiother"},{"key":"1708_CR28","doi-asserted-by":"publisher","first-page":"14760","DOI":"10.1038\/s41598-018-33034-5","volume":"8","author":"C Debus","year":"2018","unstructured":"Debus C, Afshar-Oromieh A, Floca R, Ingrisch M, Knoll M, Debus J, et al. Feasibility and robustness of dynamic 18F-FET PET based tracer kinetic models applied to patients with recurrent high-grade glioma prior to carbon ion irradiation. Sci Rep. 2018;8:14760.","journal-title":"Sci Rep"},{"key":"1708_CR29","doi-asserted-by":"publisher","first-page":"e0216111","DOI":"10.1371\/journal.pone.0216111","volume":"14","author":"DF Fleischmann","year":"2019","unstructured":"Fleischmann DF, Unterrainer M, Corradini S, Rottler M, F\u00f6rster S, la Foug\u00e8re C, et al. Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation. PLoS ONE. 2019;14:e0216111.","journal-title":"PLoS ONE"},{"key":"1708_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.radonc.2018.08.019","volume":"130","author":"I Popp","year":"2019","unstructured":"Popp I, Bott S, Mix M, Oehlke O, Schimek-Jasch T, Nieder C, et al. Diffusion-weighted MRI and ADC versus FET-PET and GdT1w-MRI for gross tumor volume (GTV) delineation in re-irradiation of recurrent glioblastoma. Radiother Oncol. 2019;130:121\u201331.","journal-title":"Radiother Oncol"},{"key":"1708_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13014-020-01744-8","volume":"16","author":"M Carles","year":"2021","unstructured":"Carles M, Popp I, Starke MM, Mix M, Urbach H, Schimek-Jasch T, et al. FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation? Radiat Oncol. 2021;16:46.","journal-title":"Radiat Oncol"},{"key":"1708_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.adro.2017.02.002","volume":"2","author":"AM Chen","year":"2017","unstructured":"Chen AM, Cao M, Hsu S, Lamb J, Mikaeilian A, Yang Y, et al. Magnetic resonance imaging guided reirradiation of recurrent and second primary head and neck cancer. Adv Radiat Oncol. 2017;2:167\u201375.","journal-title":"Adv Radiat Oncol"},{"key":"1708_CR33","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00066-018-1293-3","volume":"194","author":"J Schatteman","year":"2018","unstructured":"Schatteman J, Van Gestel D, Berwouts D, De Gersem W, De Kerf G, De Neve W, et al. A feasibility study on adaptive 18F-FDG-PET-guided radiotherapy for recurrent and second primary head and neck cancer in the previously irradiated territory. Strahlenther Onkol. 2018;194:727\u201336.","journal-title":"Strahlenther Onkol"},{"key":"1708_CR34","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1080\/0284186X.2018.1512753","volume":"57","author":"T Skj\u00f8tskift","year":"2018","unstructured":"Skj\u00f8tskift T, Evensen ME, Furre T, Moan JM, Amdal CD, Bogsrud TV, et al. Dose painting for re-irradiation of head and neck cancer. Acta Oncol. 2018;57:1693\u20139.","journal-title":"Acta Oncol"},{"key":"1708_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phro.2020.04.001","volume":"14","author":"SP Ng","year":"2020","unstructured":"Ng SP, Cardenas CE, Elhalawani H, Pollard C, Elgohari B, Fang P, et al. Comparison of tumor delineation using dual energy computed tomography versus magnetic resonance imaging in head and neck cancer re-irradiation cases. Phys Imaging Radiat Oncol. 2020;14:1\u20135.","journal-title":"Phys Imaging Radiat Oncol"},{"key":"1708_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4103\/0973-1482.95169","volume":"8","author":"DN Sharma","year":"2012","unstructured":"Sharma DN, Rath GK, Kumar R, Malhotra A, Kumar S, Pandjatcharam J, et al. Positron emission tomography scan for predicting clinical outcome of patients with recurrent cervical carcinoma following radiation therapy. J Cancer Res Ther. 2012;8:23\u20137.","journal-title":"J Cancer Res Ther"},{"key":"1708_CR37","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.ijrobp.2020.07.014","volume":"108","author":"S Bergamin","year":"2020","unstructured":"Bergamin S, Eade T, Kneebone A, Booth J, Hsiao E, Schembri GP, et al. Interim results of a prospective prostate-Specific membrane Antigen-Directed focal stereotactic reirradiation trial for locally recurrent prostate cancer. Int J Radiat Oncol Biol Phys. 2020;108:1172\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1708_CR38","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.3390\/cancers14081943","volume":"14","author":"M Michalet","year":"2022","unstructured":"Michalet M, Riou O, Cottet-Moine J, Castan F, Gourgou S, Valdenaire S, et al. Magnetic Resonance-Guided reirradiation for local recurrence within the prostate or in the prostate bed: One-Year clinical results of a prospective registry study. Cancers (Basel). 2022;14:1943.","journal-title":"Cancers (Basel)"},{"key":"1708_CR39","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11060-022-04011-w","volume":"158","author":"WG Breen","year":"2022","unstructured":"Breen WG, Youland RS, Giri S, Jacobson SB, Pafundi DH, Brown PD, et al. Initial results of a phase II trial of 18F-DOPA PET-guided re-irradiation for recurrent high-grade glioma. J Neurooncol. 2022;158:323\u201330.","journal-title":"J Neurooncol"},{"key":"1708_CR40","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3390\/jpm12091491","volume":"12","author":"G Pirrone","year":"2022","unstructured":"Pirrone G, Matrone F, Chiovati P, Manente S, Drigo A, Donofrio A, et al. Predicting local failure after partial prostate Re-Irradiation using a Dosiomic-Based machine learning model. J Pers Med. 2022;12:1491.","journal-title":"J Pers Med"},{"key":"1708_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-023-03164-3","volume":"21","author":"T Liu","year":"2023","unstructured":"Liu T, Dong D, Zhao X, Ou X-M, Yi J-L, Guan J, et al. Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study. BMC Med. 2023;21:1\u201313.","journal-title":"BMC Med"},{"key":"1708_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13014-023-02271-y","volume":"18","author":"L Boldrini","year":"2023","unstructured":"Boldrini L, Romano A, Chiloiro G, Corradini S, De Luca V, Verusio V, et al. Magnetic resonance guided SBRT reirradiation in locally recurrent prostate cancer: a multicentric retrospective analysis. Radiat Oncol. 2023;18:84.","journal-title":"Radiat Oncol"},{"key":"1708_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13014-023-02219-2","volume":"18","author":"JB Bell","year":"2023","unstructured":"Bell JB, Jin W, Goryawala MZ, Azzam GA, Abramowitz MC, Diwanji T, et al. Delineation of recurrent glioblastoma by whole brain spectroscopic magnetic resonance imaging. Radiat Oncol. 2023;18:37.","journal-title":"Radiat Oncol"},{"key":"1708_CR44","doi-asserted-by":"publisher","first-page":"101192","DOI":"10.1016\/j.adro.2023.101192","volume":"8","author":"Y Takagawa","year":"2023","unstructured":"Takagawa Y, Suzuki M, Yamaguchi H, Seto I, Azami Y, Machida M, et al. Outcomes and prognostic factors for locally recurrent rectal cancer treated with proton beam therapy. Adv Radiat Oncol. 2023;8:101192.","journal-title":"Adv Radiat Oncol"},{"key":"1708_CR45","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11060-014-1513-3","volume":"119","author":"S Liu","year":"2014","unstructured":"Liu S, Lu T, Zhao C, Shen J, Tian Y, Guan Y, et al. Temporal lobe injury after re-irradiation of locally recurrent nasopharyngeal carcinoma using intensity modulated radiotherapy: clinical characteristics and prognostic factors. J Neurooncol. 2014;119:421\u20138.","journal-title":"J Neurooncol"},{"key":"1708_CR46","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.semradonc.2020.02.003","volume":"30","author":"SC Kamran","year":"2020","unstructured":"Kamran SC, Zelefsky M, Nguyen PL, Lawton CAF. To radiate or not to radiate-The challenges of pelvic reirradiation. Semin Radiat Oncol. 2020;30:238\u201341.","journal-title":"Semin Radiat Oncol"},{"key":"1708_CR47","doi-asserted-by":"publisher","first-page":"8863","DOI":"10.1200\/JCO.2005.03.4157","volume":"23","author":"SE Combs","year":"2005","unstructured":"Combs SE, Thilmann C, Edler L, Debus J, Schulz-Ertner D. Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution. J Clin Oncol. 2005;23:8863\u20139.","journal-title":"J Clin Oncol"},{"key":"1708_CR48","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5306\/wjco.v5.i2.142","volume":"5","author":"EW Larson","year":"2014","unstructured":"Larson EW, Peterson HE, Lamoreaux WT, MacKay AR, Fairbanks RK, Call JA, et al. Clinical outcomes following salvage gamma knife radiosurgery for recurrent glioblastoma. World J Clin Oncol. 2014;5:142\u20138.","journal-title":"World J Clin Oncol"},{"key":"1708_CR49","doi-asserted-by":"publisher","first-page":"165","DOI":"10.5114\/jcb.2016.60452","volume":"8","author":"H Kunogi","year":"2016","unstructured":"Kunogi H, Wakumoto Y, Yamaguchi N, Horie S, Sasai K. Focal partial salvage low-dose-rate brachytherapy for local recurrent prostate cancer after permanent prostate brachytherapy with a review of the literature. J Contemp Brachytherapy. 2016;8:165\u201372.","journal-title":"J Contemp Brachytherapy"},{"key":"1708_CR50","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1097\/RLU.0000000000004167","volume":"47","author":"H Dang","year":"2022","unstructured":"Dang H, Zhang J, Wang R, Liu J, Fu H, Lin M, et al. Glioblastoma recurrence versus radiotherapy injury: combined model of diffusion kurtosis imaging and 11\u00a0C-MET using PET\/MRI May increase accuracy of differentiation. Clin Nucl Med. 2022;47:e428\u201336.","journal-title":"Clin Nucl Med"},{"key":"1708_CR51","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/neuonc\/noz166","volume":"21","author":"A Bashir","year":"2019","unstructured":"Bashir A, Mathilde Jacobsen S, M\u00f8lby Henriksen O, Broholm H, Urup T, Grunnet K, et al. Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET). Neuro Oncol. 2019;21:1595\u2013606.","journal-title":"Neuro Oncol"},{"key":"1708_CR52","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/neuonc\/not199","volume":"16","author":"C Kratochwil","year":"2014","unstructured":"Kratochwil C, Combs SE, Leotta K, Afshar-Oromieh A, Rieken S, Debus J, et al. Intra-individual comparison of 18F-FET and 18F-DOPA in PET imaging of recurrent brain tumors. Neuro Oncol. 2014;16:434\u201340.","journal-title":"Neuro Oncol"},{"key":"1708_CR53","doi-asserted-by":"publisher","first-page":"109486","DOI":"10.1016\/j.radonc.2023.109486","volume":"181","author":"I Sidibe","year":"2023","unstructured":"Sidibe I, Tensaouti F, Gilhodes J, Cabarrou B, Filleron T, Desmoulin F, et al. Pseudoprogression in GBM versus true progression in patients with glioblastoma: A multiapproach analysis. Radiother Oncol. 2023;181:109486.","journal-title":"Radiother Oncol"},{"key":"1708_CR54","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.nicl.2016.02.016","volume":"11","author":"T Kazda","year":"2016","unstructured":"Kazda T, Bulik M, Pospisil P, Lakomy R, Smrcka M, Slampa P, et al. Advanced MRI increases the diagnostic accuracy of recurrent glioblastoma: single institution thresholds and validation of MR spectroscopy and diffusion weighted MR imaging. Neuroimage Clin. 2016;11:316\u201321.","journal-title":"Neuroimage Clin"},{"key":"1708_CR55","doi-asserted-by":"publisher","first-page":"e24555","DOI":"10.1097\/MD.0000000000024555","volume":"100","author":"C-C Lee","year":"2021","unstructured":"Lee C-C, Lee J-C, Huang W-Y, Juan C-J, Jen Y-M, Lin L-F. Image-based diagnosis of residual or recurrent nasopharyngeal carcinoma May be a Phantom tumor phenomenon. Med (Baltim). 2021;100:e24555.","journal-title":"Med (Baltim)"},{"key":"1708_CR56","doi-asserted-by":"publisher","first-page":"102206","DOI":"10.1016\/j.ctrv.2021.102206","volume":"98","author":"BA Jereczek-Fossa","year":"2021","unstructured":"Jereczek-Fossa BA, Marvaso G, Zaffaroni M, Gugliandolo SG, Zerini D, Corso F, et al. Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: an ESTRO ACROP Delphi consensus. Cancer Treat Rev. 2021;98:102206.","journal-title":"Cancer Treat Rev"},{"key":"1708_CR57","doi-asserted-by":"publisher","first-page":"103655","DOI":"10.1016\/j.critrevonc.2022.103655","volume":"174","author":"A Beddok","year":"2022","unstructured":"Beddok A, Calugaru V, de Marzi L, Graff P, Dumas J-L, Goudjil F, et al. Clinical and technical challenges of cancer reirradiation: words of wisdom. Crit Rev Oncol\/Hematol. 2022;174:103655.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"1708_CR58","doi-asserted-by":"publisher","unstructured":"Beddok A, Saint-Martin C, Krhili S, Eddine CA, Champion L, Chilles A et al. Curative high-dose reirradiation for patients with recurrent head and neck squamous cell carcinoma using IMRT or proton therapy: outcomes and analysis of patterns of failure. Head Neck. 2022;44(11):2452\u201364. https:\/\/doi.org\/10.1002\/hed.27153","DOI":"10.1002\/hed.27153"},{"key":"1708_CR59","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.oraloncology.2016.07.012","volume":"61","author":"DN Margalit","year":"2016","unstructured":"Margalit DN, Rawal B, Catalano PJ, Haddad RI, Goguen LA, Annino DJ, et al. Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrences. Oral Oncol. 2016;61:19\u201326.","journal-title":"Oral Oncol"},{"key":"1708_CR60","doi-asserted-by":"publisher","unstructured":"Tsien CI, Pugh SL, Dicker AP, Raizer JJ, Matuszak MM, Lallana EC et al. NRG Oncology\/RTOG1205: A randomized phase II trial of concurrent bevacizumab and reirradiation versus bevacizumab alone as treatment for recurrent glioblastoma. J Clin Oncol. 2022;41(6):1285\u201395. https:\/\/doi.org\/10.1200\/JCO.22.00164","DOI":"10.1200\/JCO.22.00164"},{"key":"1708_CR61","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.radonc.2021.12.019","volume":"167","author":"P Navarria","year":"2022","unstructured":"Navarria P, Pessina F, Clerici E, Bellu L, Franzese C, Franzini A, et al. Re-irradiation for recurrent high grade glioma (HGG) patients: results of a single arm prospective phase 2 study. Radiother Oncol. 2022;167:89\u201396.","journal-title":"Radiother Oncol"},{"key":"1708_CR62","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.ijrobp.2007.08.015","volume":"70","author":"R Mayer","year":"2008","unstructured":"Mayer R, Sminia P. Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys. 2008;70:1350\u201360.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1708_CR63","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.radonc.2017.09.039","volume":"125","author":"S M\u00f8ller","year":"2017","unstructured":"M\u00f8ller S, Munck Af Rosensch\u00f6ld P, Costa J, Law I, Poulsen HS, Engelholm SA, et al. Toxicity and efficacy of re-irradiation of high-grade glioma in a phase I dose- and volume escalation trial. Radiother Oncol. 2017;125:223\u20137.","journal-title":"Radiother Oncol"},{"key":"1708_CR64","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1200\/JCO.2008.20.0691","volume":"27","author":"T Tanvetyanon","year":"2009","unstructured":"Tanvetyanon T, Padhya T, McCaffrey J, Zhu W, Boulware D, Deconti R, et al. Prognostic factors for survival after salvage reirradiation of head and neck cancer. J Clin Oncol. 2009;27:1983\u201391.","journal-title":"J Clin Oncol"},{"key":"1708_CR65","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.radonc.2014.06.003","volume":"111","author":"N Riaz","year":"2014","unstructured":"Riaz N, Hong JC, Sherman EJ, Morris L, Fury M, Ganly I, et al. A nomogram to predict loco-regional control after re-irradiation for head and neck cancer. Radiother Oncol. 2014;111:382\u20137.","journal-title":"Radiother Oncol"},{"key":"1708_CR66","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ijrobp.2017.06.012","volume":"100","author":"MC Ward","year":"2018","unstructured":"Ward MC, Riaz N, Caudell JJ, Dunlap NE, Isrow D, Zakem SJ, et al. Refining patient selection for reirradiation of head and neck squamous carcinoma in the IMRT era: A Multi-institution cohort study by the MIRI collaborative. Int J Radiation Oncology*Biology*Physics. 2018;100:586\u201394.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"1708_CR67","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.oraloncology.2019.01.022","volume":"90","author":"MC Ward","year":"2019","unstructured":"Ward MC, Lee NY, Caudell JJ, Zajichek A, Awan MJ, Koyfman SA, et al. A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck. Oral Oncol. 2019;90:80\u20136.","journal-title":"Oral Oncol"},{"key":"1708_CR68","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s41591-020-1041-y","volume":"26","author":"B Norgeot","year":"2020","unstructured":"Norgeot B, Quer G, Beaulieu-Jones BK, Torkamani A, Dias R, Gianfrancesco M, et al. Minimum information about clinical artificial intelligence modeling: the MI-CLAIM checklist. Nat Med. 2020;26:1320\u20134.","journal-title":"Nat Med"},{"key":"1708_CR69","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/neuonc\/now058","volume":"18","author":"NL Albert","year":"2016","unstructured":"Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, et al. Response assessment in Neuro-Oncology working group and European association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol. 2016;18:1199\u2013208.","journal-title":"Neuro Oncol"},{"key":"1708_CR70","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11060-013-1059-9","volume":"112","author":"AH Shah","year":"2013","unstructured":"Shah AH, Snelling B, Bregy A, Patel PR, Tememe D, Bhatia R, et al. Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality? J Neurooncol. 2013;112:141\u201352.","journal-title":"J Neurooncol"},{"key":"1708_CR71","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00259-018-4180-3","volume":"46","author":"M Lundemann","year":"2019","unstructured":"Lundemann M, Munck Af Rosensch\u00f6ld P, Muhic A, Larsen VA, Poulsen HS, Engelholm S-A, et al. Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma. Eur J Nucl Med Mol Imaging. 2019;46:603\u201313.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1708_CR72","doi-asserted-by":"publisher","first-page":"694","DOI":"10.2967\/jnumed.107.048082","volume":"49","author":"Y Terakawa","year":"2008","unstructured":"Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, et al. Diagnostic accuracy of 11\u00a0C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med. 2008;49:694\u20139.","journal-title":"J Nucl Med"},{"key":"1708_CR73","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00259-014-2959-4","volume":"42","author":"N Galldiks","year":"2015","unstructured":"Galldiks N, Dunkl V, Stoffels G, Hutterer M, Rapp M, Sabel M, et al. Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET. Eur J Nucl Med Mol Imaging. 2015;42:685\u201395.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1708_CR74","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s00259-018-4240-8","volume":"46","author":"O Humbert","year":"2019","unstructured":"Humbert O, Bourg V, Mondot L, Gal J, Bondiau P-Y, Fontaine D, et al. 18F-DOPA PET\/CT in brain tumors: impact on multidisciplinary brain tumor board decisions. Eur J Nucl Med Mol Imaging. 2019;46:558\u201368.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1708_CR75","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.radonc.2022.03.021","volume":"171","author":"S Welz","year":"2022","unstructured":"Welz S, Paulsen F, Pfannenberg C, Reimold M, Reischl G, Nikolaou K, et al. Dose escalation to hypoxic subvolumes in head and neck cancer: A randomized phase II study using dynamic [18F]FMISO PET\/CT. Radiother Oncol. 2022;171:30\u20136.","journal-title":"Radiother Oncol"},{"key":"1708_CR76","doi-asserted-by":"publisher","first-page":"e026666","DOI":"10.1136\/bmjopen-2018-026666","volume":"9","author":"D Pasquier","year":"2019","unstructured":"Pasquier D, Le Deley M-C, Tresch E, Cormier L, Duterque M, Nenan S, et al. GETUG-AFU 31: a phase I\/II multicentre study evaluating the safety and efficacy of salvage stereotactic radiation in patients with intraprostatic tumour recurrence after external radiation therapy-study protocol. BMJ Open. 2019;9:e026666.","journal-title":"BMJ Open"},{"key":"1708_CR77","doi-asserted-by":"publisher","first-page":"616291","DOI":"10.3389\/fonc.2020.616291","volume":"10","author":"BR Tocco","year":"2020","unstructured":"Tocco BR, Kishan AU, Ma TM, Kerkmeijer LGW, Tree AC. MR-Guided radiotherapy for prostate cancer. Front Oncol. 2020;10:616291.","journal-title":"Front Oncol"},{"key":"1708_CR78","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJG, Giammarile F, Tatsch K, Eschner W, et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328\u201354.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1708_CR79","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1148\/radiol.10101157","volume":"258","author":"H Hricak","year":"2011","unstructured":"Hricak H, Brenner DJ, Adelstein SJ, Frush DP, Hall EJ, Howell RW, et al. Managing radiation use in medical imaging: a multifaceted challenge. Radiology. 2011;258:889\u2013905.","journal-title":"Radiology"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-025-01708-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-025-01708-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-025-01708-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:02:02Z","timestamp":1760148122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-025-01708-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":79,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["1708"],"URL":"https:\/\/doi.org\/10.1007\/s11912-025-01708-9","relation":{},"ISSN":["1534-6269"],"issn-type":[{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"17 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}